TAUNS Laboratories, Inc.
197A.T · JPX
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥9,266,630 | ¥9,424,891 | ¥1,244,375 | ¥6,347,420 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥247,777 | ¥2,706,864 | ¥3,051,248 | ¥942,166 |
| Inventory | ¥5,883,526 | ¥4,717,448 | ¥4,586,923 | ¥4,588,361 |
| Other Curr. Assets | ¥50,075 | ¥35,733 | ¥555,240 | ¥16,536 |
| Total Curr. Assets | ¥15,476,605 | ¥16,915,714 | ¥9,456,910 | ¥12,035,639 |
| Property Plant & Equip (Net) | ¥12,279,213 | ¥7,905,227 | ¥4,402,141 | ¥3,683,201 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥3,836,768 | ¥3,720,871 | ¥3,910,135 | ¥4,137,738 |
| Long-Term Investments | ¥4,889,440 | ¥686,505 | ¥537,693 | ¥389,382 |
| Tax Assets | ¥0 | ¥0 | ¥473,736 | ¥613,176 |
| Other NC Assets | ¥33,268 | ¥33,008 | ¥25,283 | ¥22,127 |
| Total NC Assets | ¥21,038,689 | ¥12,345,611 | ¥9,348,988 | ¥8,845,624 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥36,515,294 | ¥29,261,325 | ¥18,805,898 | ¥20,881,263 |
| Liabilities | – | – | – | – |
| Payables | ¥1,199,041 | ¥1,482,761 | ¥1,143,423 | ¥1,390,887 |
| Short-Term Debt | ¥5,614,919 | ¥5,232,000 | ¥4,232,000 | ¥1,932,000 |
| Tax Payable | ¥0 | ¥1,706,274 | ¥0 | ¥3,575,666 |
| Deferred Revenue | ¥78,606 | ¥0 | ¥19,807 | ¥132,142 |
| Other Curr. Liab. | ¥1,623,616 | ¥1,043,853 | ¥986,217 | ¥1,756,778 |
| Total Curr. Liab. | ¥9,529,874 | ¥10,474,442 | ¥6,517,961 | ¥8,936,795 |
| LT Debt | ¥8,809,081 | ¥4,307,000 | ¥2,236,000 | ¥2,968,000 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥556,304 | ¥619,491 | ¥1,395,855 | ¥1,480,521 |
| Other NC Liab. | ¥202,363 | ¥193,634 | ¥166,210 | ¥139,641 |
| Total NC Liab. | ¥9,567,748 | ¥5,120,125 | ¥3,798,065 | ¥4,588,162 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥19,097,622 | ¥15,594,567 | ¥10,316,026 | ¥13,524,957 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥289,771 | ¥200,000 | ¥100,000 | ¥100,000 |
| Retained Earnings | ¥14,307,551 | ¥10,777,852 | ¥5,603,766 | ¥4,468,903 |
| AOCI | ¥39,362 | ¥5,606 | ¥2,805 | ¥4,102 |
| Other Equity | ¥7,915 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥17,417,670 | ¥13,666,758 | ¥8,489,871 | ¥7,356,305 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥36,515,294 | ¥29,261,325 | ¥18,805,897 | ¥20,881,262 |
| Net Debt | ¥5,157,370 | ¥114,109 | ¥5,223,625 | -¥1,447,420 |